1,755
Views
0
CrossRef citations to date
0
Altmetric
Case Series

Clinical Characteristics and Outcomes of Discharged COVID-19 Patients With Reoccurrence of SARS-CoV-2 RNA

ORCID Icon, , , , , & show all
Pages 663-671 | Received 17 May 2020, Accepted 13 Oct 2020, Published online: 22 Oct 2020

References

  • World Health Organization . Novel coronavirus (2019-nCoV) situation report [EB/OL]. (2020). www.who.int/docs/default-source/coronaviruse/situation-reports/20200330-sitrep-70-covid-19.pdf?sfvrsn=7e0fe3f8_2
  • An J , LiaoX, XiaoTet al. Clinical characteristics of the recovered COVID-19 patients with re-detectable positive RNA test. medRxiv.doi: https://doi.org/10.1101/2020.03.26.20044222 (2020).
  • National Health Commission of the People’s Republic of China , National Administration of Traditional Chinese Medicine. Novel coronavirus infected pneumonia treatment program, Trial version 6 [S]. (2020).
  • Lan L , XuD, YeGet al. Positive RT-PCR test results in patients recovered from COVID-19. JAMA, 323(15), 1502–1503 (2020).
  • Gousseff M , PenotP, GallayLet al. Clinical recurrence of COVID-19 symptoms after recovery:viral relapse, reinfection or inflammatory rebound? J. Infect. doi: https://doi.org/10.1016/j.jinf.2020.06.073 (2020) ( Epub ahead of print).
  • Huang C , WangY, LiXet al. Clinical features of patients infected with 2019 novel coronavirus pneumonia in Wuhan, China. Lancet, 395(10223), 497–506 (2020).
  • The multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for Chloroquine in the Treatment of Novel Coronavirus Pneumonia . Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia. Chin. J. Tuberc. Respir. Dis., 43(3), 185–188 (2020).
  • Zhao Q , HuC, FengRet al. Investigation of the mental health of patients with novel coronavirus pneumonia. Chin. J. Neurol. doi:10.3760/cma.j.cn113694-20200220-00102 (2020) ( Epub ahead of print).
  • Chen L , LiuH, LiuWet al. Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia. Chin. J. Tuberc. Respir. Dis., 43(3), 203–208 (2020).
  • Zhao X . Suggestions casted to the novel coronavirus nucleic acid amplification test from viral pneumonia pathogenesis. Chin. J. Lab. Med. doi:10.3760/cma.j.issn.1009-9158.2020.0009 (2020) ( Epub ahead of print).
  • Holshue ML , DeBoltC, LindquistSet al. First case of 2019 novel Coronavirus in the United States. N. Engl. J. Med., 382(10), 929–936 (2020).
  • Wölfel R , CormanVM, GuggemosWet al. Virological assessment of hospitalized patients with COVID-2019. Nature, 581(7809), 465–469 (2020).
  • Li P , LiZ, ZhaoSet al. Preliminary study of serum 2019-nCoV IgM and IgG antibodies in the diagnosis of novel Coronavirus pneumonia. Chin. J. Lab. Med. doi:10.3760/cma.j.cn114452-20200302-00155 (2020) ( Epub ahead of print).
  • Wang J , WangBJ, YangJCet al. Advances in the research of mechanism of pulmonary fibrosis induced by Corona Virus Disease 2019 and the corresponding therapeutic measures. Chin. J. Burns. doi:10.3760/cma.j.cn501120-20200307-00132 (2020) ( Epub ahead of print).
  • Yang T , YuX, HeXet al. Early clinical manifestations and pulmonary imaging analysis of patients with novel coronavirus pneumonia. Chin. J. Emerg. Med. doi:10.3760/cma.j.issn.1671-0282.2020.0005 (2020) ( Epub ahead of print).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.